Lipopharma
Palma De Mallorca
About Lipopharma
Lipopharma is a pioneering clinical-stage biopharmaceutical company that focuses its activities on the discovery, rational design and clinical development of a new generation of medicines that act through the selective regulation of membrane lipids, a novel therapeutic strategy known as “Membrane Lipid Therapy” (MLT). Lipopharma arose as an academic spin-off, founded to turn new scientific breakthroughs and discoveries made by scientists at the Institute of Health Science Research (IUNICS - part of the University of the Balearic Islands in Mallorca, Spain) into a new class of innovative lipid regulator therapeutic agents that they believe have dramatic game-changing potential in the treatment of life-threatening conditions like cancer, CNS, inflammatory or metabolic diseases
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: Less than $1M
- Total funding: $7.5M
- Last round: Grant (Jan 2018)
- Website: lipopharma.com
- Phone: 34 97 143 98 86
Industries & Categories
Biotechnology, Life Science, Medical, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/lipopharma-211360 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.